Skip to content

Ultragenyx Pharmaceutical Inc.

RARE · XNAS

CIK 1515673fmd_05WHSA5VP05HDWX8DP3ZQAA0SVManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2012 to Sep 30, 2026, 56 periods

AI-written

A model wrote this from the company's own SEC filings and our standardized facts. It is not reported fact, not an analyst's estimate, not a rating and not investment advice. Every claim shows what it rests on.

Loading